MDT · News · 20260916N
Regulatory Approval Milestones
Medtronic plc · 2026-09-16 · Importance 7 · Surprise 60 · In source text
The U.S. FDA cleared Medtronic’s LigaSure RAS Maryland jaw device for use with the Hugo robotic-assisted surgery system on September 16, 2026. The instrument seals and cuts vessels up to 7mm and operates with the Valleylab FT10 energy platform. The clearance expands Hugo’s U.S. robotic-surgery instrument portfolio after the product’s European introduction in 2025, while the LigaSure technology has been used in more than 45 million procedures worldwide.
Key facts
- The U.S. FDA has cleared Medtronic's LigaSure™ RAS Maryland jaw device for use with the Hugo™ robotic-assisted surgery (RAS) system. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | The U.S. FDA has cleared Medtronic's LigaSure™ RAS Maryland jaw device for use with the Hugo™ robotic-assisted surgery (RAS) system. |